financetom
Business
financetom
/
Business
/
US FDA warns against California facility making compounded weight-loss drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA warns against California facility making compounded weight-loss drugs
Nov 4, 2024 11:19 AM

Nov 1 (Reuters) - The U.S. Food and Drug Administration

on Friday warned patients and health care professionals not to

use compounded drugs, including versions of popular weight-loss

treatments, made by California-based Fullerton Wellness.

Fullerton Wellness is a facility that makes compounded

versions of Novo Nordisk's semaglutide and Eli

Lilly's ( LLY ) tirzepatide injections, among others.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved